Reply

Affiliations

Comment

Glenn J Jaffe. Ophthalmology. 2017 Aug.

. 2017 Aug;124(8):e62-e63.

doi: 10.1016/j.ophtha.2017.03.024.

¹ Duke Eye Center, Durham, North Carolina. Electronic address: jaffe001@mc.duke.edu.

No abstract available

Comment on

Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
Jaffe GJ, Lin P, Keenan RT, Ashton P, Skalak C, Stinnett SS. Jaffe GJ, et al. Ophthalmology. 2016 Sep;123(9):1940-8. doi: 10.1016/j.ophtha.2016.05.025. Epub 2016 Jul 13. Ophthalmology. 2016. PMID: 27421623 Clinical Trial.
Re: Jaffe et al.: Injectable fluocinolone acetonide long-acting implant for noninfectious intermediate uveitis, posterior uveitis, and panuveitis: 2-year results (Ophthalmology. 2016;123:1940-1948).
Shrivastav A, Mayor R, Agarwal M, Venkatesh R, Singh S. Shrivastav A, et al. Ophthalmology. 2017 Aug;124(8):e62. doi: 10.1016/j.ophtha.2017.03.023. Ophthalmology. 2017. PMID: 28734339 No abstract available.